Laminar
Laminar Inc. is a medical device company developing investigational LAAX technology to eliminate the left atrial appendage in non-valvular atrial fibrillation patients. Founded in 2019 in Santa Rosa, California, it was acquired by Johnson & Johnson MedTech for $400 million in November 2023.
- Company typePrivate
- Founded2019
- HeadquartersSanta Rosa, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Laminar does
Laminar Inc. is a medical device company founded in 2019 and headquartered in Santa Rosa, California, focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. The company's core offering is an investigational LAAX technology for structural-heart and left-atrial-appendage management — a device-based approach to a structural cardiac intervention. At acquisition, Laminar operated with 11-50 employees and had no commercial product disclosed in available sources. Early-stage funding came from Sante Ventures. The company's underlying business model centered on developing and eventually commercializing an LAA elimination device through the regulated FDA medical-device pathway.
In November 2023, Johnson & Johnson MedTech acquired Laminar Inc. for $400 million, integrating it as a wholly-owned subsidiary within J&J's cardiovascular division. The acquisition was part of J&J MedTech's broader cardiovascular strategy, which included over $30 billion in cardiovascular deals spanning Laminar, Shockwave Medical, and V-Wave. Post-acquisition, Laminar's technology gains access to J&J MedTech's global clinical, regulatory, and distribution infrastructure. Pricing, go-to-market details, and current commercial revenue are not publicly disclosed. (Note: Several data sources reference a separate "Laminar" — a physical AI / spectral-sensor company serving CPG manufacturers including Coca-Cola, AB InBev, Danone, and Unilever. This appears to be a distinct entity unrelated to the medical-device Laminar Inc. under analysis.)
Laminar firmographics
Firmographics- Name
- Laminar
- Legal name
- Laminar Inc.
- Website
- https://laminarlaa.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Laminar Inc. is a medical device company developing investigational LAAX technology to eliminate the left atrial appendage in non-valvular atrial fibrillation patients. Founded in 2019 in Santa Rosa, California, it was acquired by Johnson & Johnson MedTech for $400 million in November 2023.
- Ownership category
- akta.pro rank
Laminar industry classification
Industry- Product category
- Cardiac Medical Devices
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
Keywords
Where Laminar is headquartered
LocationHeadquarters
- HQ city
- Santa Rosa
- HQ country
- United States
- HQ region
- North America
Markets served
Laminar business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Laminar product offering
Product offeringCore offering
Laminar Inc. is a medical device company developing investigational LAAX technology for eliminating the left atrial appendage in patients with non-valvular atrial fibrillation. The company's product targets left atrial appendage closure as a structural-heart intervention. Laminar was acquired by Johnson & Johnson MedTech in November 2023 for $400 million.
Product overview
Laminar is a physical AI solutions provider that offers a self-driving manufacturing platform for the consumer packaged goods (CPG) industry. The company provides spectral sensors and ML models that enable autonomous factory operations. The company's innovations transform factory operations and have been deployed across six continents for major clients including Coca-Cola, AB InBev, Danone, and Unilever.
Differentiator
Problem solved
Functional benefit
Products and services
- LAAX (investigational left atrial appendage closure device)
Companies that use Laminar
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles1 record
Laminar technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Laminar partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights4 records
Laminar competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Medtronic is a broad cardiovascular incumbent with cardiac surgery and structural-heart offerings relevant to LAA management; it represents a potential alternative acquirer or competitor to Laminar's LAAX positioning.
- Edwards Lifesciences: Edwards Lifesciences is a structural-heart leader (surgical and transcatheter valves) whose portfolio and physician relationships are directly relevant to the LAA closure category in which Laminar operates.
- Abbott: Abbott is a diversified cardiovascular incumbent with structural-heart and electrophysiology franchises that overlap with Laminar's LAA closure and AF stroke-prevention focus, and could expand into LAA closure as a competitor or consolidator.
Direct peers
- Boston Scientific: Boston Scientific markets the Watchman family of left atrial appendage closure devices, the dominant direct competitor to Laminar's LAAX technology in the structural-heart stroke-prevention space for AF patients.
- AtriCure: AtriCure is a structural-heart company developing left atrial appendage management solutions, including the AtriClip surgical LAA exclusion device, making it a direct comparator in the LAA elimination category that Laminar targets.
Others
- Johnson & Johnson MedTech: J&J MedTech is the parent entity that acquired Laminar and now houses the LAAX program; it is included as the structural integration vehicle and primary commercial channel through which the technology's value will be realized.
Emerging players
- Conformal Medical: Conformal Medical is an early-to-mid stage developer of a next-generation LAA closure device, making it an emerging direct competitor to Laminar's LAAX in the structural-heart stroke-prevention space.
- Append Medical: Append Medical is developing a transcatheter LAA exclusion technology targeting the same non-valvular AF stroke-prevention patient population as Laminar, representing an emerging peer in the investigational LAA closure category.
- CardioFocus: CardioFocus is an early-stage player in interventional cardiac technologies, including AF-related ablation and structural interventions, with partial overlap to Laminar's structural-heart AF portfolio.
- SentreHEART: SentreHEART developed LARIAT, a percutaneous LAA ligation system, positioning it as an emerging or niche peer to Laminar in LAA elimination approaches for AF-related stroke prevention.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
Laminar social profiles
Digital presenceLaminar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Laminar leadership team
Management profileNumber of profiles
Laminar funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Laminar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Laminar
What does Laminar do?
Laminar Inc. is a medical device company developing investigational LAAX technology for eliminating the left atrial appendage in patients with non-valvular atrial fibrillation. The company's product targets left atrial appendage closure as a structural-heart intervention. Laminar was acquired by Johnson & Johnson MedTech in November 2023 for $400 million.
Is Laminar a public or private company?
Laminar is a private company. It is classified as corporate owned and is currently acquired.
When was Laminar founded?
Laminar was founded in 2019. It employs 11 to 50 people.
Where is Laminar based?
Laminar is headquartered in Santa Rosa, United States, in the North America region.
Who are Laminar's main competitors?
Broad incumbents on record are Medtronic, Edwards Lifesciences and Abbott. Direct peers are Boston Scientific and AtriCure. Johnson & Johnson MedTech is listed as an others. Emerging players are Conformal Medical, Append Medical, CardioFocus and SentreHEART.
Does Laminar have an API?
No public API is recorded for Laminar.
What industry is Laminar in?
Laminar's product category is Cardiac Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices.